News
-
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
Mainz Biomed and Thermo Fisher Scientific sign a collaboration agreement for the development of next generation colorectal cancer screening product for global markets -
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
Mainz Biomed reports 4% revenue increase in Mid-Year 2024 Financial Results with 32% decrease in loss from operations. Company highlights successful studies at ASCO and outlines strategic plan for 2025 -
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
Mainz Biomed reports increasing demand for enhanced ColoAlert product leading to transition by existing partners to new version, featuring at Medizinische Woche Baden-Baden -
